APA (7th ed.) Citation

M, S., E, J., A, K., JW, C., L, R., S, A., . . . S, G. (2020). The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer. Journal of gastrointestinal cancer, 51(3), 868. https://doi.org/10.1007/s12029-019-00316-8

Chicago Style (17th ed.) Citation

M, Shusterman, et al. "The Neutrophil-to-Lymphocyte Ratio Is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer." Journal of Gastrointestinal Cancer 51, no. 3 (2020): 868. https://doi.org/10.1007/s12029-019-00316-8.

MLA (9th ed.) Citation

M, Shusterman, et al. "The Neutrophil-to-Lymphocyte Ratio Is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer." Journal of Gastrointestinal Cancer, vol. 51, no. 3, 2020, p. 868, https://doi.org/10.1007/s12029-019-00316-8.